Search Results - "Reka Vajda"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2
  3. 3

    Changes in the health status of the population of Central and Eastern European countries between 1990 and 2010 by Boncz, Imre, Vajda, Réka, Ágoston, István, Endrei, Dóra, Sebestyén, Andor

    Published in The European journal of health economics (01-05-2014)
    “…Objective The aim of this study was to analyse change in the health status of the population in the countries of Central and Eastern Europe (CEE) since 1990,…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Attendance of the fourth (2008-2009) screening round of the Hungarian organized, nationwide breast cancer screening program by Boncz, Imre, Döbrőssy, Lajos, Péntek, Zoltán, Kovács, Attila, Budai, András, Imre, László, Vajda, Réka, Sebestyén, Andor

    Published in Orvosi hetilap (01-12-2013)
    “…Organised, nationwide screening for breast cancer with mammography in the age group between 45 and 65 years with 2 years screening interval started in Hungary…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Predicting cervical screening and HPV vaccination attendance of Roma women in Hungary: community nurse contribution is key by Pakai, Annamária, Mihály-Vajda, Réka, Horváthné, Zsuzsanna Kívés, Gabara, Krisztina Szabó, Bogdánné, Eszter Basa, Oláh, András, Zrínyi, Miklós, Újváriné, Adrienn Siket

    Published in BMC nursing (30-01-2022)
    “…HPV screening/vaccination has been observed lower for ethic minorities. Understanding factors that predict and can improve attendance is therefore key. Hence,…”
    Get full text
    Journal Article
  8. 8

    Experience and Attitude of Colorectal Screening Pilot Program Participants Regarding Screening and Screening Programs in Hungary by Kívés, Zsuzsanna, Endrei, N Dóra, Vajda, Réka, Máté, Orsolya, Németh, Noémi, Vincze, Áron, Boncz, Imre

    Published in Iranian journal of public health (01-12-2022)
    “…In 2015, in Csongrád County (Hungary), a general practitioner based colorectal screening model program was implemented by the financial support of the European…”
    Get full text
    Journal Article
  9. 9

    Assessment of the pilot program for cervical cancer screening by health visitors by Vajda, Réka, Árváné Egri, Csilla, Kovács, Attila, Budai, András, Döbrőssy, Lajos, Koiss, Róbert, Kívés, Zsuzsanna, Boncz, Imre

    Published in Orvosi hetilap (01-03-2017)
    “…Within the tender (6.1.3.A-13/1-2013-0001) supported by the European Union, we wished to involve health visitors into the organized cervical cancer screening…”
    Get more information
    Journal Article
  10. 10

    Assessing the impact of Hungary's public health product tax: an interrupted time series analysis by Csákvári, Tímea, Elmer, Diána, Németh, Noémi, Komáromy, Márk, Mihály-Vajda, Réka, Boncz, Imre

    Published in Central European journal of public health (01-03-2023)
    “…Imposing taxes on unhealthy goods can generate income, raise people's health awareness, and eventually decrease the prevalence of chronic diseases. Our aim was…”
    Get full text
    Journal Article
  11. 11

    Reasons for Non-Appearance on Organized Cervical Screening in Hungary by Pakai, Annamária, Brantmüller, Éva, Réka, Vajda, Karácsony, Ilona, Balázs, Péter

    “…The occurrence of cervix cancer is outstandingly high in Zala County, which is situated in the Western Transdanubian region of Hungary. The aim of our study…”
    Get more information
    Journal Article
  12. 12

    A Védőnői Méhnyakszűrési Pilot Program Értékelése és a Méhnyakrákból Eredő Betegségteher Vizsgálata by Vajda, Réka

    Published 01-01-2018
    “…A daganatos megbetegedések vezető egészségügyi problémát jelentenek világszerte. A Nemzeti Rákkutató Ügynökség (IARC) becslése szerint az összes megbetegedés…”
    Get full text
    Dissertation
  13. 13

    Epidemiological disease burden and annual health insurance treatment cost of colorectal cancer in Hungary by Kívés, Zsuzsanna, Endrei, Dóra, Elmer, Diána, Csákvári, Tímea, Kajos, Luca Fanni, Boncz, Imre, Mangel, László, Mihály-Vajda, Réka

    Published in Orvosi hetilap (28-03-2021)
    “…Összefoglaló. Bevezetés: Magyarországon a vastag- és a végbéldaganat mindkét nem esetében a harmadik leggyakoribb daganatos megbetegedés és a második…”
    Get more information
    Journal Article
  14. 14

    The effect of generic price competition on drug consumption and health insurance pharmaceutical expenditures in Hungary by Répásy, Balázs, Endrei, Dóra, Zemplényi, Antal, Agoston, István, Hornyák, Lajos, Nagy, Zsolt, Csákvári, Tímea, Vajda, Réka, Boncz Imre

    Published in Acta pharmaceutica Hungarica (2015)
    “…The aim of our study was to analyze the Hungarian montelukast sodium drug market. We examined the effect of the appearance of generic drugs on the price and…”
    Get more information
    Journal Article
  15. 15

    Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary by Boncz, Imre, Döbrõssy, Lajos, Péntek, Zoltán, Kovács, Attila, Budai, András, Vajda, Réka, Sebestyén, Andor

    Published in Magyar onkologia (01-09-2013)
    “…Organised, nationwide screening for breast cancer with mammography in the age group of 45-65 years with 2 years screening interval started in Hungary in…”
    Get more information
    Journal Article
  16. 16

    Annual epidemiological and health insurance burden of cervical cancer in Hungary by Mihály-Vajda, Réka, Boncz, Imre, Elmer, Diána, Csákvári, Tímea, Németh, Noémi, Kajos, Luca Fanni, Pónusz-Kovács, Dalma, Bódis, József, Kívés, Zsuzsanna

    Published in Orvosi hetilap (28-03-2021)
    “…Összefoglaló. Bevezetés: A méhnyakdaganatok kérdése kiemelten fontos, megoldatlan népegészségügyi probléma. A betegség terhe magas, ami elsősorban az alacsony…”
    Get more information
    Journal Article
  17. 17

    CHEK1 expression and inhibitors in TP53 mutant cancer by Õsz, Ágnes, Aszódi, Boglárka, Vajda, Réka, Keserû, Miklós György, Moll, Herwig P, Casanova, Emilio, Gyõrffy, Balázs

    Published in Magyar onkologia (09-12-2019)
    “…The most frequently mutated gene in human tumors is TP53 and its mutation significantly deteriorates patients' survival. However, to date no targeted therapy…”
    Get more information
    Journal Article